Vanguard Fiduciary Trust
PTCT icon

Vanguard Fiduciary Trust’s PTC Therapeutics PTCT Stock Holding History

Vanguard Fiduciary Trust’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48M Buy
587,887
+34,229
+6% +$2.47M 0.01% 881
2026
Q1 		$37.7M Buy
+553,658
New +$39.2M 0.01% 935

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Vanguard Fiduciary Trust's PTCT Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its PTC Therapeutics (PTCT) stake by 6.2% in Q2 2026, buying an estimated $2.47M and bringing the position to 587,887 shares worth $48M. The position accounts for 0.01% of the portfolio, ranked #881.

Vanguard Fiduciary Trust first reported a position in PTCT in Q1 2026 and has held it in 2 quarters since. 380 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Vanguard Fiduciary Trust held 587,887 shares of PTC Therapeutics worth $48M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 34,229 PTC Therapeutics shares in Q2 2026, an estimated $2.47M.
  • PTC Therapeutics made up 0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #881 holding.
  • Vanguard Fiduciary Trust first reported a position in PTC Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 380 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.